Akro is a distinctive perfume brand founded by the talented duo of Olivier Cresp and his daughter Anais. Since its inception in 2018, Akro has captivated fragrance enthusiasts with its innovative compositions, culminating in its latest release in 2022. The brand is known for its unique and evocative scents, like Ink, crafted by the esteemed nose Olivier Cresp. Each fragrance tells a story, blending creativity and artistry to create olfactory experiences that resonate deeply with wearers.

In a different sphere, Akero Therapeutics operates as a biopharmaceutical company dedicated to pioneering therapies for liver diseases and metabolic disorders. With a particular focus on non-alcoholic steatohepatitis (NASH) and other serious liver health issues, Akero is committed to addressing critical unmet medical needs. The company combines scientific expertise and innovation, striving to advance treatments that can significantly improve patient outcomes. Their strategic financial planning and growth potential underscore their ambition in the competitive landscape of biopharmaceuticals.